News · 26 weeks10%
2025-12-142026-06-07
Mix090d
No activity.
Latest news
25 items- PRDefining Wellness Centers Names Bill Morrison Chief Financial OfficerExperienced Healthcare Executive Joins Leadership Team to Support Continued Growth Backed by Fulcrum Equity PartnersJACKSON, Miss., March 9, 2026 /PRNewswire/ -- Defining Wellness Centers (www.definingwellness.com) today announced that veteran healthcare executive Bill Morrison has joined the organization as Chief Financial Officer. Morrison brings more than 25 years of experience helping scale healthcare and behavioral health companies and will oversee the company's financial strategy during a period of continued growth backed by Atlanta-based growth equity firm Fulcrum Equity Partners.
- SECSEC Form 15-12G filed by Accolade Inc.15-12G - Accolade, Inc. (0001481646) (Filer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Accolade Inc.SCHEDULE 13D/A - Accolade, Inc. (0001481646) (Subject)
- SECSEC Form 25-NSE filed by Accolade Inc.25-NSE - Accolade, Inc. (0001481646) (Subject)
- SECSEC Form S-8 POS filed by Accolade Inc.S-8 POS - Accolade, Inc. (0001481646) (Filer)
- SECSEC Form S-8 POS filed by Accolade Inc.S-8 POS - Accolade, Inc. (0001481646) (Filer)
- SECSEC Form S-8 POS filed by Accolade Inc.S-8 POS - Accolade, Inc. (0001481646) (Filer)
- SECSEC Form S-8 POS filed by Accolade Inc.S-8 POS - Accolade, Inc. (0001481646) (Filer)
- SECSEC Form S-8 POS filed by Accolade Inc.S-8 POS - Accolade, Inc. (0001481646) (Filer)
- INSIDERChief Executive Officer Singh Rajeev returned $10,429,525 worth of shares to the company (1,483,574 units at $7.03), closing all direct ownership in the company (SEC Form 4)4 - Accolade, Inc. (0001481646) (Issuer)
- INSIDERSEC Form 4 filed by Director Lepore Dawn G4 - Accolade, Inc. (0001481646) (Issuer)
- INSIDERDirector Kent Cindy returned $84,093 worth of shares to the company (11,962 units at $7.03), closing all direct ownership in the company (SEC Form 4)4 - Accolade, Inc. (0001481646) (Issuer)
- INSIDERDirector Wadors Patricia L returned $195,146 worth of shares to the company (27,759 units at $7.03), closing all direct ownership in the company (SEC Form 4)4 - Accolade, Inc. (0001481646) (Issuer)
- INSIDERDirector Klein Peter S returned $199,153 worth of shares to the company (28,329 units at $7.03), closing all direct ownership in the company (SEC Form 4)4 - Accolade, Inc. (0001481646) (Issuer)
- INSIDERDirector Jordan Jeffrey D returned $38,148,063 worth of shares to the company (5,426,467 units at $7.03), closing all direct ownership in the company (SEC Form 4)4 - Accolade, Inc. (0001481646) (Issuer)
- INSIDERDirector Brodsky Jeffrey S returned $329,074 worth of shares to the company (46,810 units at $7.03), closing all direct ownership in the company (SEC Form 4)4 - Accolade, Inc. (0001481646) (Issuer)
- INSIDERDirector Nabel Elizabeth G returned $295,133 worth of shares to the company (41,982 units at $7.03), closing all direct ownership in the company (SEC Form 4)4 - Accolade, Inc. (0001481646) (Issuer)
- INSIDERChief Financial Officer Barnes Stephen H. returned $2,157,324 worth of shares to the company (306,874 units at $7.03), closing all direct ownership in the company (SEC Form 4)4 - Accolade, Inc. (0001481646) (Issuer)
- INSIDEREVP General Counsel Eskew Richard returned $465,323 worth of shares to the company (66,191 units at $7.03), closing all direct ownership in the company (SEC Form 4)4 - Accolade, Inc. (0001481646) (Issuer)
- INSIDERPresident Cavanaugh Robert N returned $1,562,178 worth of shares to the company (222,216 units at $7.03), closing all direct ownership in the company (SEC Form 4)4 - Accolade, Inc. (0001481646) (Issuer)
- INSIDERDirector Hilton Michael W returned $2,432,296 worth of shares to the company (345,988 units at $7.03), closing all direct ownership in the company (SEC Form 4)4 - Accolade, Inc. (0001481646) (Issuer)
- SECAccolade Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Accolade, Inc. (0001481646) (Filer)
- PRTranscarent Completes Merger With AccoladeCreating the Most Comprehensive Health and Care Platform for Employers and Health Plans Serving 20 Million Members & 1,700 Employer and Health Plan Clients Today Transcarent announced the successful completion of its merger with Accolade, the leading health advocacy, expert medical opinion, and virtual primary care company in the market. The combined organization now serves over 20 million Members and more than 1,700 employer and health plan clients as the One Place for Health and Care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250407811112/en/ With the completion of the transaction, Transcarent will offer a health and car
- INSIDERChief Financial Officer Barnes Stephen H. converted options into 1,568 shares and sold $3,014 worth of shares (431 units at $6.99), increasing direct ownership by 0.37% to 306,874 units (SEC Form 4)4 - Accolade, Inc. (0001481646) (Issuer)
- INSIDERPresident Cavanaugh Robert N converted options into 1,568 shares and sold $3,846 worth of shares (550 units at $6.99), increasing direct ownership by 0.46% to 222,216 units (SEC Form 4)4 - Accolade, Inc. (0001481646) (Issuer)
ACCD FAQ
7 questionsWhat does Accolade Inc. do?
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to...Where does ACCD stock trade?
Accolade Inc. (ACCD) is listed on NASDAQ.What sector and industry is ACCD in?
Accolade Inc. operates in the Consumer Discretionary sector, Business Services industry.When did Accolade Inc. go public?
Accolade Inc. (ACCD) completed its IPO in 2020.What are analysts saying about ACCD?
Accolade Inc. has had 8 recent analyst actions on file. The most recent action was from Needham: Buy with a $800.00 price target on 2024-06-28. Recent price targets range from $800.00 to $1800.00.What companies are similar to ACCD?
Notable peers in the same industry include FLT (FleetCor Technologies Inc.), NVEI (Nuvei Corporation Subordinate Voting Shares), NLSN (Nielsen N.V.), STMP (Stamps.com Inc.), ENV (Envestnet Inc). Compare ACCD side-by-side with any of them on Quantisnow.How can I track ACCD on Quantisnow?
Quantisnow aggregates Accolade Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ACCD to receive live email and push alerts on every new disclosure.